Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Greenwich LifeSciences Inc
GLSI | US
13.39
USD-0.14
-1.03%
GLSI | US
About Greenwich LifeSciences Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
13.39
Open
13.60
High
13.76
Low
13.36
Greenwich LifeSciences Inc. a clinical-stage biopharmaceutical company focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2 an immunotherapy which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell Inc. and changed its name to Greenwich LifeSciences Inc. in March 2018. Greenwich LifeSciences Inc. was incorporated in 2006 and is headquartered in Stafford Texas.
View LessGLSI | US
Risk
47.8
Sharpe
0.64
Luna's Score
36/100
Recommendation
Sell
Luna says (GLSI | US)
What's Working
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
49.3%1 month
47.8%3 months
59.7%6 months
69.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
31.77
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-21.23
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-10.53M
MarketCap
176.01M
MarketCap(USD)
176.01M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-123.67
Short ratio
11.82
Short perc.
7.78
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
2.08
Range1M
2.98
Range3M
4.48
Volumes: Market Activity
Rel. volume
0.39
Price X volume
133.00K
